All Covishield side-effects were disclosed: Serum Institute of India

Amid concerns over Thrombosis (blood clotting) and Thrombocytopenia Syndrome (low platelet count), or TTS, rare complications associated with Covishield, the vaccine administered to protect against Covid-19, Pune-based Serum Institute of IndiaIndiaIndia (SII), which manufactured the vaccine in association with British pharma giant AstraZeneca, stated on Wednesday that it had disclosed its side-effects, including TTS, in the packaging insert in 2021.

The pharma giant has begun the worldwide withdrawal of its Covid-19 vaccine due to a ‘surplus of available updated vaccines’ that target new variants of the virus. (FILE PHOTO)

Laying emphasis on safety as a priority, the company also highlighted Covishield’s role in saving millions of lives globally.